Pain Therapeutics
Date: | 18-May-15 to 19-May-15 |
Location: | Holiday Inn Bloomsbury / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
Through a series of interactive presentations and panel discussions, this event will give you access to key industry leaders, spotlighting principles and illustrative examples on current activities and trends in clinical and pre-clinical evidence-based and best-practice-based pain medicine. Highlighting research and developments in the field of pain relief this is an event that you will not want to miss!
Benefits of attending in 2015:
• New for 2015 - Presentations on personalized medicine for pain, biomarkers and CGRP receptor antagonists for migraine treatment
• Learn about Grunenthal’s latest screening approach for neuropathic pain and pain models
• Hear timely case studies from Merck and Afferent Pharmaceuticals
• Spotlight sessions - Latest updates on developments in targeting nerve growth factors
• Discover latest advances in the treatment of pain from leading, pharma, biotech and academic experts from the industry
• Interactive panel discussion the reviewing validity of animal models for chronic pain
In addition, don’t miss the two interactive post conference workshops taking place at the Holiday Inn Bloomsbury, London, UK on Wednesday 20th May 2015:
Healthcare Innovation - A patient centred approach
Workshop Leader: Zakera Kali, Founder, Insight Consultancy
In vitro techniques and models for pain drug development:“Clinical trial in a dish”
Workshop Leaders:
Dr Uma Anand, Research Associate, Medicine, Imperial College London
Professor Praveen Anand, Professor Neurology, Medicine, Imperial College London
Professor Yuri Korchev, Professor of Biophysiology, Medicine, Imperial College London
Dr Andrew Shevchuk, Non Clinical Lecturer In Nano-Medicine, Medicine, Imperial College London
HOW TO REGISTER
Book before 27th February to save £300
Register online at http://www.smi-online.co.uk/2015pain-therapeutics2.asp
Contact Kinga Gradalska on +44 (0) 20 7827 6192 or email kgradalska@smi-online.co.uk
Benefits of attending in 2015:
• New for 2015 - Presentations on personalized medicine for pain, biomarkers and CGRP receptor antagonists for migraine treatment
• Learn about Grunenthal’s latest screening approach for neuropathic pain and pain models
• Hear timely case studies from Merck and Afferent Pharmaceuticals
• Spotlight sessions - Latest updates on developments in targeting nerve growth factors
• Discover latest advances in the treatment of pain from leading, pharma, biotech and academic experts from the industry
• Interactive panel discussion the reviewing validity of animal models for chronic pain
In addition, don’t miss the two interactive post conference workshops taking place at the Holiday Inn Bloomsbury, London, UK on Wednesday 20th May 2015:
Healthcare Innovation - A patient centred approach
Workshop Leader: Zakera Kali, Founder, Insight Consultancy
In vitro techniques and models for pain drug development:“Clinical trial in a dish”
Workshop Leaders:
Dr Uma Anand, Research Associate, Medicine, Imperial College London
Professor Praveen Anand, Professor Neurology, Medicine, Imperial College London
Professor Yuri Korchev, Professor of Biophysiology, Medicine, Imperial College London
Dr Andrew Shevchuk, Non Clinical Lecturer In Nano-Medicine, Medicine, Imperial College London
HOW TO REGISTER
Book before 27th February to save £300
Register online at http://www.smi-online.co.uk/2015pain-therapeutics2.asp
Contact Kinga Gradalska on +44 (0) 20 7827 6192 or email kgradalska@smi-online.co.uk
Exhibitors
Professor Anthony Jones, Professor of Neuro-Rheumatology, Human Pain Research Group, University of Manchester; Professor Richard Knowles, CEO, Arachos Pharma; Dr Emanuele Sher, Senior Research Advisor, Neuroscience, Discovery, Lilly Research Centre, Eli Lilly; Dr Anthony P. Ford, Chief Scientific Officer, Afferent Pharmaceuticals; Dr Richard Butt, Senior Director, Research Project Leader, Clinical Research, Pfizer; Dr Shahnaz Yusaf, Investigator Biopharm Innovation BDU, GlaxoSmithKline; Dr Ian Bell, Principal Scientist, Discovery Chemistry, Merck; Dr Mark T. Brown, MD, Executive Director, Clinical Program Leader for Osteoarthritis and Cancer Pain Studies, Pfizer Inc;Dr Gregor Bahrenberg, Associate Scientific Director, Grunenthal
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today